Scaling Up Community-based Noncommunicable Disease Research Into Practice in Pokhara Metropolitan City of Nepal

NARecruitingINTERVENTIONAL
Enrollment

2,070

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
HypertensionType 2 Diabetes Mellitus (T2DM)Tobacco Smoking
Interventions
BEHAVIORAL

SCALE-NCD

"1. FCHV home visits every three months, including~ * For hypertension i. Blood pressure measurement with digital BP devices ii. Lifestyle counseling iii. Referral if uncontrolled BP (≥140/90 mmHg) for 3 months~ * For type 2 diabetes i. Fasting blood glucose measurement with glucometer ii. Lifestyle counseling focusing on diabetes management iii. Referral if uncontrolled diabetes (≥126mg/dl) for 3 months~ * For current smokers i. Smoking cessation counseling ii. Referral for nicotine replacement therapy if request by participants~2. Mobile phone messages, including~ * Lifestyle modification~ * Conveyed as voice or text messages, depending on participant preference"

Trial Locations (1)

Unknown

RECRUITING

Pokhara Metropolitan City, Pokhara

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins Bloomberg School of Public Health

OTHER